covid 19 News and Research

RSS

Study: Integrating palliative care earlier in care trajectory benefits COVID-19 patients

Critical care nurses are ideally positioned to drive full integration of palliative care into the care of all patients who are seriously ill, including patients with COVID-19, according to an article published in the December issue of Critical Care Nurse (CCN).

2 Dec 2020

Elsevier launches a new book on COVID-19

Elsevier, a global research publishing and information analytics provider, recently launched the English version of COVID-19: The Essentials of Prevention and Treatment. A digital version of the book is freely available to download on Elsevier's Novel Coronavirus Information Center here.

2 Dec 2020

Researchers develop telomerase gene therapy for treating different pathologies

After several years of research and many joint scientific publications, molecular biologists Maria Blasco (National Cancer Research Centre, CNIO) and Fàtima Bosch (Universitat Autònoma de Barcelona, UAB) have developed a telomerase gene therapy for the treatment of different pathologies related to shortening telomeres and, therefore, ageing.

2 Dec 2020

Researchers evaluate the most appropriate test for COVID-19

Until a vaccine is available, curbing the coronavirus pandemic relies heavily on how quickly a potentially exposed individual can be tested and quarantined.

2 Dec 2020

New, improved probes could make it easier to validate rapid COVID-19 diagnostic tests

Nanoengineers at the University of California San Diego have developed new and improved probes, known as positive controls, that could make it easier to validate rapid, point-of-care diagnostic tests for COVID-19 across the globe.

2 Dec 2020

Study highlights pros and cons of AI-based apps used to benefit older adults

A new analysis from North Carolina State University highlights the realistic pros and cons of apps and other technologies that use artificial intelligence (AI) to benefit older adults, including those facing dementia and cognitive decline.

2 Dec 2020

Pharmacophore model helps find key protease inhibitor responsible for COVID-19

A team of San Diego Supercomputer Center (SDSC) researchers recently created a pharmacophore model and conducted data mining of the database of drugs approved by the U.S. Federal Drug Administration (FDA) to find potential inhibitors of papain-like protease of SARS-CoV2, one of the main viral proteins responsible for COVID-19.

2 Dec 2020

Immune mechanism in COVID-19 patients triggers cytokine storm

Researchers at the University of São Paulo (USP) in Brazil have demonstrated for the first time that in COVID-19 patients an immune mechanism known as the inflammasome participates in activation of the inflammatory process that can damage several organs and even lead to death.

2 Dec 2020

CARES Act helped reduce social interaction of viral spread

As case rates of COVID-19 reach new heights across the nation, many states and cities are tightening stay-at-home restrictions to stop the spread.

1 Dec 2020

Repurposed mouse model sheds light on spectrum of COVID-19 disease symptoms

A repurposed mouse model can develop symptoms of both severe COVID-19 (lung damage, blood clots, abnormal blood vessels, and death) and also of milder disease, including loss of the sense of smell, according to a recent University of Iowa study published in Nature.

1 Dec 2020

PTC299 inhibits SARS-CoV-2 replication and suppresses production of inflammatory cytokines

In an article published in the journal Virus Research, a team of researchers from various US institutions discussed their study that evaluated the antiviral activity of PTC299 against a group of RNA viruses in vitro.

1 Dec 2020

OHDSI awarded $10 million FDA contract to support Biologics Effectiveness and Safety program

Researchers within the Observational Health Data Services and Informatics (OHDSI) community were recently awarded a $10 million contract from the U.S. Food and Drug Administration (FDA) to provide support to the Biologics Effectiveness and Safety (BEST) program, which was launched by the FDA Center for Biologics Evaluation and Research (CBER) in 2017.

1 Dec 2020

Cleaning surfaces with hydrogen peroxide-based disinfectants may pollute indoor air

Cleaning surfaces with hydrogen peroxide-based disinfectants has the potential to pollute the air and pose a health risk, according to research led by University of Saskatchewan.

1 Dec 2020

Three leading organizations join hands to address global challenges in dementia

To address the growing public health crisis of dementia, three leading organizations announced funding for 23 small-scale pilot projects as part of this year's Pilot Awards for Global Brain Health Leaders.

1 Dec 2020

Alcohol-free hand sanitizer works just as well as alcohol-based products to control COVID-19

A new study from researchers at Brigham Young University finds that alcohol-free hand sanitizer is just as effective at disinfecting surfaces from the COVID-19 virus as alcohol-based products.

1 Dec 2020

COVID-19 may exacerbate mental health symptoms among pregnant and postpartum women

Though childbirth is often anticipated with optimism and enthusiasm, approximately 10 to 20 percent of pregnant individuals also experience mental health challenges during the weeks immediately before and after birth.

1 Dec 2020

Nanomedicine's giant step into the fight against the COVID-19

A recent editorial in Nature Nanotechnology discusses the enormous feat of scientific innovation, with messenger RNA (mRNA)-based vaccines developed to deliver the gene sequence of specific SARS-CoV-2 viral proteins into host cells using nanotechnology platforms.

1 Dec 2020

Older adults may be coping with COVID-19's mental health effects better than other age groups

Older adults are especially vulnerable to the effects of the COVID-19 pandemic--with higher risks of severe complications and death, and potentially greater difficulties accessing care and adapting to technologies such as telemedicine.

1 Dec 2020

Research suggests plant flavonols could serve as effective antivirals for SARS-CoV-2

Researchers in Algeria have reviewed some of the evidence suggesting that flavonols commonly found in many plants and vegetables could be used as a therapeutic approach to coronavirus disease 2019 (COVID-19).

1 Dec 2020

KU Leuven vaccine candidate works against yellow fever and SARS-CoV-2 infection

Virologists at the Rega Institute at KU Leuven (Belgium) have developed a vaccine candidate against Covid-19 based on the yellow fever vaccine, which as a result also works against yellow fever. Results published today in Nature show that the vaccine protects hamsters from infection with the SARS-CoV-2 coronavirus after a single dose.

1 Dec 2020

covid 19 News and Research

Study: Integrating palliative care earlier in care trajectory benefits COVID-19 patients

Elsevier launches a new book on COVID-19

Researchers develop telomerase gene therapy for treating different pathologies

Researchers evaluate the most appropriate test for COVID-19

New, improved probes could make it easier to validate rapid COVID-19 diagnostic tests

Study highlights pros and cons of AI-based apps used to benefit older adults

Pharmacophore model helps find key protease inhibitor responsible for COVID-19

Immune mechanism in COVID-19 patients triggers cytokine storm

CARES Act helped reduce social interaction of viral spread

Repurposed mouse model sheds light on spectrum of COVID-19 disease symptoms

PTC299 inhibits SARS-CoV-2 replication and suppresses production of inflammatory cytokines

OHDSI awarded $10 million FDA contract to support Biologics Effectiveness and Safety program

Cleaning surfaces with hydrogen peroxide-based disinfectants may pollute indoor air

Three leading organizations join hands to address global challenges in dementia

Alcohol-free hand sanitizer works just as well as alcohol-based products to control COVID-19

COVID-19 may exacerbate mental health symptoms among pregnant and postpartum women

Nanomedicine's giant step into the fight against the COVID-19

Older adults may be coping with COVID-19's mental health effects better than other age groups

Research suggests plant flavonols could serve as effective antivirals for SARS-CoV-2

KU Leuven vaccine candidate works against yellow fever and SARS-CoV-2 infection

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News